共 36 条
- [2] [Anonymous], J CLIN ONCOL
- [3] [Anonymous], 2010, Cancer Facts Figures 2010
- [9] Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1127 - 1135
- [10] A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (17): : 1320 - 1330